Evidence map›Paper›PMID 26912063›Full record

ArticleMolecular neurodegeneration2016

Frontotemporal dementia: insights into the biological underpinnings of disease through gene co-expression network analysis.

Raffaele Ferrari, Paola Forabosco, Jana Vandrovcova, Juan A Botía, Sebastian Guelfi, Jason D Warren, UK Brain Expression Consortium (UKBEC), Parastoo Momeni, Michael E Weale, Mina Ryten and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecular neurodegeneration, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Identification of a novel mutation in MEF2C gene in an atypical patient with frontotemporal lobar degeneration.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Raffaele FerrariDepartment of Molecular Neuroscience, Institute of Neurology, University College London, Russell Square House, 9-12 Russell Square House, London, WC1N 3BG, UK. r.ferrari@ucl.ac.uk.
Paola ForaboscoIstituto di Ricerca Genetica e Biomedica, Cittadella Universitaria di Cagliari, 09042, Monserrato, Sardinia, Italy. paola.forabosco@cnr.it.
Jana VandrovcovaDepartment of Molecular Neuroscience, Institute of Neurology, University College London, Russell Square House, 9-12 Russell Square House, London, WC1N 3BG, UK. jana.vandrovcova@csc.mrc.ac.uk.
Juan A BotíaDepartment of Molecular Neuroscience, Institute of Neurology, University College London, Russell Square House, 9-12 Russell Square House, London, WC1N 3BG, UK. j.botia@ucl.ac.uk.
Sebastian GuelfiDepartment of Molecular Neuroscience, Institute of Neurology, University College London, Russell Square House, 9-12 Russell Square House, London, WC1N 3BG, UK. m.guelfi@ucl.ac.uk.
Jason D WarrenDementia Research Centre, UCL Institute of Neurology, University College London, London, WC1N 3BG, UK. jason.warren@ucl.ac.uk.
UK Brain Expression Consortium (UKBEC)
Parastoo MomeniOmixy, 107 Cheapside, EC2V 6DN, London, UK. parastoo@omixy.com.
Michael E WealeKing's College London, Department of Medical & Molecular Genetics, Guy's Hospital, London, SE1 9RT, UK. michael.weale@kcl.ac.uk.
Mina RytenDepartment of Molecular Neuroscience, Institute of Neurology, University College London, Russell Square House, 9-12 Russell Square House, London, WC1N 3BG, UK. mina.ryten@ucl.ac.uk.
John HardyDepartment of Molecular Neuroscience, Institute of Neurology, University College London, Russell Square House, 9-12 Russell Square House, London, WC1N 3BG, UK. j.hardy@ucl.ac.uk.
Guy's Hospital · GBInstitute of Genetic and Biomedical Research · ITInstitute of Molecular Medicine · INKing's College London · GBTiGenix (Spain) · ESUK Dementia Research Institute · GB

Funding

Medical Research Council G0802462Medical Research Council MR/L501542/1Wellcome Trust R01 NS040975 and
6 · The paper itself

Abstract

backgroundIn frontotemporal dementia (FTD) there is a critical lack in the understanding of biological and molecular mechanisms involved in disease pathogenesis. The heterogeneous genetic features associated with FTD suggest that multiple disease-mechanisms are likely to contribute to the development of this neurodegenerative condition. We here present a systems biology approach with the scope of i) shedding light on the biological processes potentially implicated in the pathogenesis of FTD and ii) identifying novel potential risk factors for FTD. We performed a gene co-expression network analysis of microarray expression data from 101 individuals without neurodegenerative diseases to explore regional-specific co-expression patterns in the frontal and temporal cortices for 12 genes (MAPT, GRN, CHMP2B, CTSC, HLA-DRA, TMEM106B, C9orf72, VCP, UBQLN2, OPTN, TARDBP and FUS) associated with FTD and we then carried out gene set enrichment and pathway analyses, and investigated known protein-protein interactors (PPIs) of FTD-genes products.

resultsGene co-expression networks revealed that several FTD-genes (such as MAPT and GRN, CTSC and HLA-DRA, TMEM106B, and C9orf72, VCP, UBQLN2 and OPTN) were clustering in modules of relevance in the frontal and temporal cortices. Functional annotation and pathway analyses of such modules indicated enrichment for: i) DNA metabolism, i.e. transcription regulation, DNA protection and chromatin remodelling (MAPT and GRN modules); ii) immune and lysosomal processes (CTSC and HLA-DRA modules), and; iii) protein meta/catabolism (C9orf72, VCP, UBQLN2 and OPTN, and TMEM106B modules). PPI analysis supported the results of the functional annotation and pathway analyses.

conclusionsThis work further characterizes known FTD-genes and elaborates on their biological relevance to disease: not only do we indicate likely impacted regional-specific biological processes driven by FTD-genes containing modules, but also do we suggest novel potential risk factors among the FTD-genes interactors as targets for further mechanistic characterization in hypothesis driven cell biology work.

Indexed as

Gene Regulatory NetworksAgingAnimalsBrain MappingFrontotemporal DementiaGenetic Predisposition to DiseaseIntercellular Signaling Peptides and ProteinsMutationRisk Factorstau ProteinsIntercellular Signaling Peptides and Proteinstau Proteins

Identifiers

PMID26912063
PMCPMC4765225
OpenAlexW2276090540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.